Skip to content
Dose Brief
Menu
No. 117 here · Grade C

KERNX Health review

Prices every dose rung in public for both molecules, which makes it one of the few rows here whose future price movements will be readable rather than inferred.

Visit KERNX Health Assume any provider we list may compensate us — we may earn a commission, at no cost to you. It never changes the score.
Semaglutide
From $129/mo (compounded, plus a one-time consultation fee)
Tirzepatide
From $229/mo (compounded, plus a one-time consultation fee)
Coverage
All 50 states
Brand-name
Compounded only

Prices read from KERNX Health's own site on . Providers change pricing without notice — check the current figure before you buy.

On the trackerNewnew to the tracker, no prior reading— Re-read 30 August 2026 after the company disputed our first entry. The published line now reads From $129/mo for semaglutide and From $229/mo for tirzepatide, both dose-laddered. Our 30 July reading recorded $199 for tirzepatide, which was the top SEMAGLUTIDE rung recorded against the wrong molecule, so treat this as a corrected first reading rather than a price movement.

The scorecard

KERNX Health scored on our six Brief Score factors. See the methodology.

Price Stability74/100
Supply Reliability72/100
Transparency82/100
Access Breadth66/100
Clinical Oversight80/100
Track Record64/100

What we like

  • Both ladders are published in full — semaglutide $129/$139/$169/$199, tirzepatide $229/$259/$279/$329 — so a price change shows up as a moved rung rather than a moved headline
  • No membership fee and no multi-month prepayment, so the monthly figure is the whole recurring cost
  • Shipping is included at every rung, which keeps the published price comparable across doses
  • Billing does not begin until a licensed provider approves treatment

The caveats

  • A one-time consultation fee of $25 to $60 sits outside the ladder, so a first month at the lowest dose is $154 rather than $129
  • The monthly price is tied to the prescribed dose, so a normal escalation raises the bill without any price change on their side
  • The dispensing pharmacy is never named publicly, so a supply disruption could not be traced to a facility
  • Injectable compounded medication only — no oral route and no brand-name pathway to fall back on
  • Cash-pay only, with lab work billed outside the plan when a provider recommends it

The brief

Best for: Readers tracking what a program will cost at dose three, not just at sign-up. Prices every dose rung in public for both molecules, which makes it one of the few rows here whose future price movements will be readable rather than inferred.

Ranked #117 of 546 providers we reviewed — see our #1 pick, CoreAge Rx, for comparison.

Visit KERNX Health

Before you decide

The questions readers ask next after reading about KERNX Health.

Closest here

The providers scoring nearest KERNX Health — the realistic shortlist if you're weighing it.

Weighing KERNX Health against one provider in particular? There is a full head-to-head with our top-ranked pick in CoreAge Rx vs KERNX Health, and every provider that outranks it is listed on the KERNX Health alternatives ranking.

More providers we track (24)

515 more are filed too — see every provider we track, ranked.

Pricing, states and verification reflect KERNX Health's public disclosures at last review; the Brief Score is our editorial judgment per the methodology. Prices change — confirm on KERNX Health's site. Not medical advice; see our disclosure.

← Back to all rankings